Economic evaluation and survival analysis of immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

European Journal of Health Economics

Volumn 5, Issue 1, 2004, Pages 58-63

  Hessel, Franz P ^a   Wegner, Christoph ^b   Müller, Johannes ^c   Glaveris, Christina ^d   Wasem, Jürgen ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^d Clinic for Internal Medicine   (Germany)

Author keywords

Autoantibodies; Cardiomyopathy; Cost effectiveness; Survival

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD PUMP; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG COST; FEMALE; FOLLOW UP; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; IMMUNOADSORPTION; MALE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

ADSORPTION; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 1542374134     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-003-0202-5     Document Type: Article

References (19)

1. Bland JM, Altman DG (1998) Survival probabilities (the Kaplan-Meier method). BMJ 317:1572
2. CCOHTA (1996) A guidance document for the costing process. CCOHTA: Ottawa
3. CCOHTA (1997) Guidelines for economic evaluation of pharmaceuticals: Canada, 2nd edn. CCOHTA: Ottawa
4. Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy - review article. N Engl J Med 331:1564-1575
5. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW (1997) Methods for the economic evaluation of health care programmes. Oxford University Press: Oxford
6. Feldman AM, McNamara DM (2000) Myocarditis. N Engl J Med 343:1388-1398
7. Felix SB, Staudt A, Dorffel WV, Stangl V, Merkel K, Pohl M, Docke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35:1590-1598
8. Gold MR, Siegel JE, Russell LB, Weinstein MC (1996) Cost-effectiveness in health and medicine. Oxford University Press: Oxford
9. Gruppe HK (1999) Empfehlungen zur gesundheitsökonomischen Evaluation - revidierte Fassung des Hannoveraner Konsens. Gesundheitsokon Qualitats-manage 4:A62-A65
10. Hessel FP, Kohlmann T, Krauth C, Nowy R, Seitz R, Siebert U, Wasem J (1999) Ökonomische Evaluation in der Rehabiliation: Prinzipien und Empfehlungen für die Leistungseffassung. DRV-Schriften 16:103-246
11. Hirth RA, Chernow ME, Miller E, Fendrick AM, Weissert WG (2000) Willingness to pay for a quality adjusted life year: In search of a standard. Med Decis Making 20:332-342
12. Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davis MK (2002) Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 23:1867-1876
13. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ (1997) The registry of the International Society for Heart and Lung Transplantation. Fourteenth official report 1997. J Heart Lung Transplant 16:691-712
14. Jünger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, Haass M (2002) Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 87:235-241
15. Mann DL (2001) Autoimmunity, immunoglobulin adsorption and dilated cardiomyopathy: has the time come for randomized clinical trials? J Am Coll Cardiol 38:184-186
16. Muller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101:385-391
17. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93:841-842
18. Schimke I, Muller J, Priem F, Kruse I, Schon B, Stein J, Kunze R, Wallukat G, Hetzer R (2001) Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol 38:178-183
19. Tamburro P, Wilber D (1992) Sudden death in idiopathic dilated cardiomyopathy. Am Heart J 124:1035-1045